Company intelligence / Profile preview

Signova

Ownership: Private
Employees: ~19
Development stage: Other

Overview

The company manufactures and markets a broad portfolio of generic and branded prescription pharmaceuticals, including oral solid dose products, liquids, narcotics, potent drugs, and extended-release tablets. It provides contract manufacturing and analytical services for both multinational and small generic pharmaceutical companies. Its product range covers multiple therapeutic categories such as anti-inflammatories, analgesics, antibiotics, gastrointestinal agents, gynecological drugs, anti-diabetics, and anti-allergics[4][5].

Therapeutic areas: Infectious DiseasesEndocrinologyImmunologyGastroenterologyNeurologyWomen's Health
Modalities: Small molecule
Industry: Biotech

Partnerships

Provides contract manufacturing for multinationals as well as small generic pharma companies[4]

Beyond the preview

Go deeper on Signova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signova.

Explore the full profile